These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7994036)

  • 1. Role of the B domain for factor VIII and factor V expression and function.
    Pittman DD; Marquette KA; Kaufman RJ
    Blood; 1994 Dec; 84(12):4214-25. PubMed ID: 7994036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
    Marquette KA; Pittman DD; Kaufman RJ
    Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells.
    Marquette KA; Pittman DD; Kaufman RJ
    J Biol Chem; 1995 Apr; 270(17):10297-303. PubMed ID: 7730335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heterologous factor V heavy chain sequences on the secretion of recombinant human factor VIII.
    Ortel TL; Moore KD; Ezban M; Kane WH
    Thromb Haemost; 1996 Jan; 75(1):36-44. PubMed ID: 8713777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.
    Pittman DD; Millenson M; Marquette K; Bauer K; Kaufman RJ
    Blood; 1992 Jan; 79(2):389-97. PubMed ID: 1730084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin-catalyzed activation of recombinant human factor V.
    Keller FG; Ortel TL; Quinn-Allen MA; Kane WH
    Biochemistry; 1995 Mar; 34(12):4118-24. PubMed ID: 7696276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms that regulate the anticoagulant function of coagulation factor V.
    Thorelli E
    Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis, assembly and secretion of coagulation factor VIII.
    Kaufman RJ; Pipe SW; Tagliavacca L; Swaroop M; Moussalli M
    Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S3-14. PubMed ID: 9607108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.
    Ortel TL; Devore-Carter D; Quinn-Allen M; Kane WH
    J Biol Chem; 1992 Feb; 267(6):4189-98. PubMed ID: 1740460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into binding interfaces of coagulation factors V and VIII and their homologues lessons from high resolution crystal structures.
    Fuentes-Prior P; Fujikawa K; Pratt KP
    Curr Protein Pept Sci; 2002 Jun; 3(3):313-39. PubMed ID: 12188899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of thrombin exosites I and II in the activation of human coagulation factor V.
    Segers K; Dahlbäck B; Bock PE; Tans G; Rosing J; Nicolaes GA
    J Biol Chem; 2007 Nov; 282(47):33915-24. PubMed ID: 17878169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII.
    Newell JL; Fay PJ
    J Biol Chem; 2007 Aug; 282(35):25367-75. PubMed ID: 17595160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.
    Michnick DA; Pittman DD; Wise RJ; Kaufman RJ
    J Biol Chem; 1994 Aug; 269(31):20095-102. PubMed ID: 8051097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
    Villoutreix BO; Dahlbäck B
    Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII.
    Pittman DD; Alderman EM; Tomkinson KN; Wang JH; Giles AR; Kaufman RJ
    Blood; 1993 Jun; 81(11):2925-35. PubMed ID: 8499631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion.
    Doering CB; Healey JF; Parker ET; Barrow RT; Lollar P
    J Biol Chem; 2004 Feb; 279(8):6546-52. PubMed ID: 14660593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V: Dr. Jeckyll and Mr. Hyde.
    Kalafatis M; Mann KG
    Adv Exp Med Biol; 2001; 489():31-43. PubMed ID: 11554589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII.
    Bukys MA; Orban T; Kim PY; Beck DO; Nesheim ME; Kalafatis M
    J Biol Chem; 2006 Jul; 281(27):18569-80. PubMed ID: 16624813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-translational requirements for functional factor V and factor VIII secretion in mammalian cells.
    Pittman DD; Tomkinson KN; Kaufman RJ
    J Biol Chem; 1994 Jun; 269(25):17329-37. PubMed ID: 8006042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.